11th Feb 2010 17:13
Standard Form TR-1 Voting rights attached to shares- Article 12(1) of directive 2004/109/EC Financial instruments - Article 11(3) of the Commission Directive 2007/14/EC
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: United Drug plc
2. Reason for the notification (please tick the appropriate box or boxes):
[x ] an acquisition or disposal of voting rights
[ ] an acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
[ ] an event changing the breakdown of voting rights
3. Full name of person(s) subject to the notification obligation:
Bank of America Corporation
4. Full name of shareholder(s) (if different from 3.):
Columbia Acorn International
Columbia Acorn Fund
Columbia Acorn International Select
Wanger International
Wanger International Select
Wanger European Smaller Companies Fund
Fairfax County Employees Retirement System
5. Date of the transaction and date on which the threshold is crossed or reached: 09.02.10
6. Date on which issuer notified; 11.02.10
7. Threshold(s) that is/are crossed or reached: crossed 8%
8. Notified details:
1.
1. 1. 1.
|
A) Voting rights attached to shares |
|||||||
|
Class/type of shares Ordinary Shares of nominal value: €0.025 each ISIN Code: IE0033024807 |
Situation previous to the Triggering transaction |
Resulting situation after the triggering transaction |
|||||
| Number of Shares |
Number of Voting rights |
Number of shares |
Number of voting rights |
% of voting rights |
|||
| Direct |
Direct |
Indirect |
Direct |
Indirect |
|||
|
|
17,705,600 |
17,142,600 |
19,955,600 |
19,345,000 |
N/A |
8.18% |
|
|
|
|
|
|
|
|
|
|
|
SUBTOTAL A (based on aggregate voting rights) |
|
|
19,955,600 |
19,345,000 |
8.18% |
||
|
B) Financial Instruments |
||||
|
Resulting situation after the triggering transaction |
||||
|
Type of financial instrument |
Expiration Date |
Exercise/Conversion Period/ Date |
Number of voting rights that may be acquired if the instrument is exercised/converted |
% of voting rights |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SUBTOTAL B (in relation to all expiration dates) |
|
|
|
|
Total (A+B) |
number of voting rights |
% of voting rights |
|
19,955,600 |
19,345,000 |
8.18% |
9. Chain of controlled undertakings through which the voting rights and/or the financial instrumentsare effectively held, if applicable:
Bank of America Corporation is the indirect parent of Columbia Wanger Asset Management L.P.
Columbia Wanger Asset Management L.P. is the investment advisor to the shareholders listed in Item 4 above.
10. In case of proxy voting:[name of the proxy holder] will cease to hold [number] voting rights as of [date]. N/a
11. Additional information:
Done in London, England on 11.02.10
This announcement has been issued through the Companies Announcement Service of
The Irish Stock Exchange.
Related Shares:
UDG.L